deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT01951274

VPD-737 for Treatment of Chronic Pruritus

A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus

Sponsor: Vyne Therapeutics Inc.

Interventions Placebo VPD-737
Updated 11 times since 2017 Last updated: May 10, 2022 Started: Oct 15, 2013 Primary completion: Dec 2, 2014 Completion: Dec 2, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01951274, this PHASE2 trial focuses on Chronic Pruritus and remains completed. Sponsored by Vyne Therapeutics Inc., it has been updated 11 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2020 · 26 months · monthly snapshotCompleted~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotCompleted~Jun 2021 – ~Apr 2022 · 10 months · monthly snapshotCompleted~Apr 2022 – ~Jun 2022 · 2 months · monthly snapshotCompleted~Jun 2022 – ~Jul 2024 · 25 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jun 2022 — Jul 2024 [monthly]

    Completed PHASE2

  4. Apr 2022 — Jun 2022 [monthly]

    Completed PHASE2

  5. Jun 2021 — Apr 2022 [monthly]

    Completed PHASE2

Show 6 earlier versions
  1. Jan 2021 — Jun 2021 [monthly]

    Completed PHASE2

  2. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE2

  3. Aug 2020 — Sep 2020 [monthly]

    Completed PHASE2

  4. Jun 2018 — Aug 2020 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Vyne Therapeutics Inc.
Data source: Vyne Therapeutics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .